Literature DB >> 22913963

Management of hypertension in the elderly population.

Raymond V Oliva1, George L Bakris.   

Abstract

Hypertension is common in people aged 65 and older. African Americans and women have a higher prevalence of hypertension than white individuals, and in those aged 70 and older, the hypertension was more poorly controlled than in those aged 60-69. The number of trials available in the elderly population compared with the general population are limited; hence, the database for strong recommendations as to goal blood pressure (BP) are limited. The American College of Cardiology with the American Heart Association has recently published a consensus report of management of hypertension in the elderly population. This review presents an overview of this consensus report and reviews specific studies that provide some novel findings regarding goal BP and progression of nephropathy. In general, the evidence strongly supports a BP goal of less than 150/80 mmHg. The evidence review for the consensus report supports a goal of <150/80 mmHg for the elderly with scant data in those over age 80. However, it was decided to set the goal to less than 140/90 mmHg unless the patient cannot tolerate it and then try for 140-145 mmHg. The data are scant at best for those over age 80 mmHg but some evidence exists for <150/80 mmHg. Diuretics and calcium antagonists are the most efficacious single agents for treatment; however, most patients will require two or more drugs to achieve such goals.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22913963     DOI: 10.1093/gerona/gls148

Source DB:  PubMed          Journal:  J Gerontol A Biol Sci Med Sci        ISSN: 1079-5006            Impact factor:   6.053


  9 in total

Review 1.  The Management of Hypertension in 2018: What Should the Targets Be?

Authors:  Waleed Ali; George Bakris
Journal:  Curr Hypertens Rep       Date:  2019-04-25       Impact factor: 5.369

2.  Prescribing patterns in the treatment of hypertension among underserved African American elderly.

Authors:  Hamed Yazdanshenas; Mohsen Bazargan; Gail Orum; Leila Loni; Navid Mahabadi; Baqar Husaini
Journal:  Ethn Dis       Date:  2014       Impact factor: 1.847

Review 3.  Hypertension in the Older Adult.

Authors:  Belinda Setters; Holly M Holmes
Journal:  Prim Care       Date:  2017-09       Impact factor: 2.186

Review 4.  Current and emerging treatment options for the elderly patient with chronic kidney disease.

Authors:  Robert G Fassett
Journal:  Clin Interv Aging       Date:  2014-01-15       Impact factor: 4.458

5.  Factors affecting medication adherence in community-managed patients with hypertension based on the principal component analysis: evidence from Xinjiang, China.

Authors:  Yuji Zhang; Xiaoju Li; Lu Mao; Mei Zhang; Ke Li; Yinxia Zheng; Wangfei Cui; Hongpo Yin; Yanli He; Mingxia Jing
Journal:  Patient Prefer Adherence       Date:  2018-05-11       Impact factor: 2.711

6.  Motivation and social-cognitive abilities in older adults: Convergent evidence from self-report measures and cardiovascular reactivity.

Authors:  Irene Ceccato; Serena Lecce; Elena Cavallini; Floris T van Vugt; Ted Ruffman
Journal:  PLoS One       Date:  2019-07-10       Impact factor: 3.240

7.  Pressure-Natriuresis Response Is Diminished in Old Age.

Authors:  Yang Gyun Kim; Ju-Young Moon; Bermseok Oh; Ho Jun Chin; Dong Ki Kim; Jung Hwan Park; Sung Joon Shin; Bum Soon Choi; Chun Soo Lim; Sang Ho Lee
Journal:  Front Cardiovasc Med       Date:  2022-02-16

8.  Recent changes in blood pressure levels, hypertension prevalence and treatment rates, and the rate of reaching target blood pressure in the elderly.

Authors:  Hiroyuki Takase; Takamitsu Tanaka; Shin Takayama; Daishi Nonaka; Masashi Machii; Tomonori Sugiura; Sumiyo Yamashita; Nobuyuki Ohte; Yasuaki Dohi
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

Review 9.  Combination therapy in the treatment of hypertension.

Authors:  Carolina Guerrero-García; Alberto Francisco Rubio-Guerra
Journal:  Drugs Context       Date:  2018-06-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.